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Background: Gastroesophageal reﬂux disease (GERD) is one of the most common causes of chronic cough
and often coexists with asthma or chronic obstructive pulmonary disease (COPD); however, it is un-
known whether there are differences in the effect of GERD on these diseases. The purpose of this study
was to assess the difference in the effect of GERD on cough-related quality of life and disease status in
asthma and COPD in a real-world setting.
Methods: Subjects were 132 patients with overall controlled asthma and 102 patients with stable COPD.
They completed the frequency scale for symptoms of GERD (FSSG), a validated Japanese questionnaire for
GERD, the Leicester Cough Questionnaire (LCQ), and the Asthma Control Test (ACT) or COPD assessment
test (CAT) questionnaires.
Results: We found that 29 (22.0%) patients with asthma and 22 (21.6%) patients with COPD had GERD.
There was no difference in the FSSG scale between the diseases. The patients with GERD, regardless of
having asthma or COPD, had lower LCQ scores affecting all health domains and lower ACT or higher CAT
scores than those without GERD. Overall, the patients with COPD had lower LCQ scores regardless of the
presence or absence of GERD. The FSSG scale was negatively correlated with the LCQ total score in
asthma and in COPD. In contrast, the FSSG scale was positively correlated with the CAT score but not with
the ACT score.
Conclusions: Patients with GERD had impaired cough-related quality of life, poor asthma control or more
symptoms and impacts of COPD.
Copyright © 2014, Japanese Society of Allergology. Production and hosting by Elsevier B.V. All rights reserved.Introduction
Gastroesophageal reﬂux disease (GERD) is one of the most
common causes of chronic cough1 and often coexists with asthma
or chronic obstructive pulmonary disease (COPD).2,3 A systematic
review reported the prevalence of GERD symptoms to be 45%e71%
in patients with asthma,2 whereas a Korean survey from the Na-
tional Health Insurance Database found the prevalence of GERD to
be 28% in patients with COPD.3 The current asthma guidelines
recommend medical management of GERD in patients with




rgology. Production and hosting by Elsthose who have nocturnal symptoms.4 Previous studies demon-
strated that COPD exacerbations were associated with GERD
symptoms.5,6 GERD not only causes coughing but also affects the
disease status in asthma and COPD, in both of which coughing is a
common symptom in itself; however, very few have studied the
differences in the effect of GERD on these diseases.7
The prevalence of GERD varies depending on the diagnostic mo-
dalities. Upper gastrointestinal endoscopy is a conventional test but
cannot deﬁnitively diagnose GERD if there is no erosive lesion.
Esophageal pH monitoring is the current gold standard but cannot
detect reﬂux events with a pH similar to that of the normal esoph-
agus.8 Several questionnaires have beendeveloped for the symptom-
based diagnosis of GERD, including a questionnaire for the diagnosis
of reﬂux disease (QUEST)9 and a frequency scale for symptoms of
GERD (FSSG).10 FSSG is the standard questionnaire used in Japan for
the diagnosis of GERD and assessment of the response to treatment.
GERD symptoms can be quantiﬁed with FSSG but not with QUEST.evier B.V. All rights reserved.
Table 1





Age, y 60 (17e81)z 73 (57e86)
Male/female 62/70z 92/10
Body mass index, kg/
m2




Pack-years 0 (0e9.5)y 51.0 (0e300.0)
FEV1, % of predicted 87.6 (23.0e145.7)z 50.2 (17.0e109.0)
FEV1/FVC, % 72.2 (25.2e100.0)z 50.2 (20.8e69.9)
ACT scorey 22.9 (9e25) NA
CAT scorey NA 11.8 (0e32)
FSSG scaley 4.7 (0e33) 5.1 (0e34)
LCQ
Total scorey 20.2 (9.5e21.0)z 18.8 (7.5e21.0)
Physical domainy 6.6 (3.6e7.0)z 6.2 (2.6e7.0)
Psychological
domainy
6.8 (2.6e7.0)z 6.2 (2.1e7.0)
Social domainy 6.8 (2.3e7.0)z 6.4 (2.5e7.0)
Data are expressed as the median (range) or No.
Abbreviations: ACT, Asthma Control Test; CAT, COPD assessment test; FEV1, forced
expiratory volume in 1 s; FSSG, frequency scale for the symptoms of GERD; FVC,
forced vital capacity; GERD, gastroesophageal reﬂux disease; LCQ, Leicester Cough
Questionnaire; NA, not applicable.
y Data are expressed as the mean (Range).
z p < 0.05 versus patients with COPD.
T. Shirai et al. / Allergology International 64 (2015) 79e8380Symptoms related not only to acid reﬂux but also to gastric dysmo-
tilitycan beevaluatedwith FSSG.10Wehypothesized that the effect of
GERDwould differ between asthma and COPD. In this cross-sectional
real-world study we assessed the effect of GERD, which was diag-
nosed by FSSG, on the cough-related quality of life and disease status
in patients with asthma and COPD. We used the Leicester Cough
Questionnaire (LCQ)11 to assess the cough-related quality of life, and
the Asthma Control Test (ACT)12 or COPD assessment test (CAT)13
questionnaires to assess the disease status.
Methods
Subjects
One hundred and thirty-two patients with bronchial asthma
and 102 patients with COPD who attended outpatient clinics at
Shizuoka General Hospital for routine check-ups between 2009 and
2011 were enrolled in this study.
The patients with asthma satisﬁed the deﬁnition of asthma of
the Global Initiative for Asthma (GINA)14 and were receiving
inhaled corticosteroids with or without other medications,
including long-acting b2-agonists, leukotriene receptor antago-
nists, or sustained release theophylline for at least 3 months. Pa-
tients were excluded from the study if they1 had had any acute viral
infections within at least 1 month before the study2; had a smoking
history of >10 pack-years3; had COPD4; had been diagnosed with
cough variant asthma; or5 were receiving proton pump inhibitors.
The patients with COPD satisﬁed the deﬁnition of the Global
Initiative for Chronic Obstructive Lung Disease (GOLD).15 They were
clinically stable and had no exacerbations, deﬁned as increased
dyspnea associated with a change in the quality and quantity of
sputum, for at least one month before the study. They were
excluded from the study if they1 had had any acute viral infections
within at least 1 month before the study2; had any history of
asthma; or3 were receiving proton pump inhibitors.
Study design
On the examination day, the patients completed the FSSG, LCQ,
and ACT or CAT questionnaires and underwent pulmonary function
tests. The protocols were approved by the Institutional Review
Board of Shizuoka General Hospital (SGH 13-01-42) and informed
consent was obtained from all subjects prior to the study.
FSSG
GERD was diagnosed by the FSSG questionnaire,10 a validated
questionnaire in the Japanese population. The FSSG consists of 12
items, each of which is quantiﬁed on a scale ranging from 0 to 4
points and the cut-off score for GERD is set at 8 points.
LCQ
Cough-related quality of life was assessed by the LCQ,11 which
comprises 19 items and three domains: physical, psychological and
social. Each item is scored between 1 and 7, with a higher score
indicating better quality of life. The total score ranges from 3 to 21.
The Japanese version was developed by Dr Akio Niimi (Nagoya City
University Graduate School of Medical Sciences) and Dr Haruhiko
Ogawa (Ishikawa-ken Saiseikai Kanazawa Hospital).
ACT
The ACT (Japanese version, supplied by GlaxoSmithKline Japan)
questionnaire consists of 5 items assessing the impact of asthma oneveryday functioning at school or work, shortness of breath,
nocturnal asthma symptoms, use of rescue medication, and the
patient's self-rating of asthma control during the previous 4
weeks.12
CAT
The CAT (Japanese version, supplied by GlaxoSmithKline Japan)
questionnaire consists of 8 items (cough, phlegm, chest tightness,
breathlessness going up hills/stairs, activity limitations at home,
conﬁdence leaving home, sleep, and energy) assessing and quan-
tifying the symptoms and impacts of COPD.13 Each item is scored
from 0 to 5, giving a total score range from 0 to 40, corresponding to
the best and worst health status, respectively.
Pulmonary function tests
Spirometry was performed using computerized equipment
(model CHESTAC-33; CHEST MI, Inc., Tokyo, Japan) according to the
standards of the American Thoracic Society.16
Statistical analysis
Comparisons between groups were made using the Krus-
kaleWallis test. The chi-square or Fisher's exact test was used to
test signiﬁcance in group differences with respect to the percentage
of patients in various categories. Correlations between variables
were performed using the Spearman rank correlation coefﬁcient.
The analysis of covariance (ANCOVA) was used to adjust for age and
gender. Stat View Version 5.0 (SAS Institute, Cary, NC, USA) was
used for statistical calculations. A p value of <0.05 was considered
signiﬁcant, and all tests were 2 sided.
Results
Characteristics of study patients
The characteristics of study patients are shown in Table 1. The
patients with asthma were younger and female-dominant, had a
T. Shirai et al. / Allergology International 64 (2015) 79e83 81higher body mass index and pulmonary function, included more
nonsmokers, and had fewer pack-years than those with COPD. The
mean ACT score of 22.9 indicated that study patients with asthma
were overall controlled. There was no difference in the mean FSSG
scale between the two groups; however, the LCQ scores in
the patients with COPD were signiﬁcantly lower than those in
the patients with asthma. These results were reanalyzed using
ANCOVA adjusting for age and gender; however, the results were
the same.Comparison between patients with asthma and GERD and those
without GERD
We found that 29 of 132 (22.0%) patients with asthma and 22 of
102 (21.6%) patients with COPD had GERD. Table 2 shows the
comparison of characteristics between patients with and without
GERD. The patients with asthma and GERDwere younger and had a
lower ACT score and more impaired cough-related quality of life
affecting all health domains than those without GERD. There was
no difference in the body mass index or pulmonary function.Comparison between patients with COPD and GERD and those
without GERD
The patients with COPD and GERD had a higher CAT score and
more impaired cough-related quality of life affecting all health
domains than those without GERD; however, there was no differ-
ence in the body mass index or pulmonary function.Comparison between patients with asthma and GERD and those
with COPD and GERD
Concerning the LCQ scores, the patients with COPD had a more
impaired psychological domain than those with asthma; however,
therewas no difference in the bodymass index, FSSG scale, and LCQ
total scores and other domains between the two groups.Table 2
Comparison of characteristics between patients with and without GERD.
Patients with asthma
GERD (þ) (n ¼ 29) GERD ()
Age, y 45 (17e78)*,** 62 (20e8
Male/female 12/17** 50/53***
Body mass index, kg/m2 21.2 (17.2e45.4) 21.9 (16.0
Non/ex/current smokers 14/9/6** 58/40/5**
Pack-years 0 (0e9.5)** 1.1 (0e9.
FEV1, % of predicted 89.9 (23.0e116.6)** 87.3 (29.6
FEV1/FVC, % 75.7 (45.6e100.0)** 71.3 (25.2
ACT score y 21.2 (9e25)* 23.4 (15e
CAT scorey NA NA
FSSG scaley 15.0 (8e33)* 1.8 (0e7)
LCQ
Total scorey 18.9 (13.0e21.0)* 20.5 (9.5e
Physical domainy 6.0 (3.6e7.0)* 6.8 (3.8e
Psychologicaly domain 6.4 (3.7e7.0)*,** 6.9 (2.6e
Social domainy 6.5 (4.8e7.0)* 6.8 (2.3e
Data are expressed as the median (range) or No.
Abbreviations: ACT, Asthma Control Test; CAT, COPD assessment test; FEV1, forced expira
capacity; GERD, gastroesophageal reﬂux disease; LCQ, Leicester Cough Questionnaire; N
*p < 0.05 versus patients without GERD.
**p < 0.05 versus patients with COPD and GERD.
***p < 0.05 versus patients with COPD and without GERD.
y Data are expressed as the mean (Range).Comparison between patients with asthma and without GERD and
those with COPD and without GERD
Concerning the LCQ scores, the patients with COPD had a more
impaired cough-related quality of life affecting all health domains
than those with asthma.
Correlation between FSSG scale and LCQ score and disease status
In patients with asthma, the FSSG scale was negatively corre-
lated with the LCQ total score (r¼0.328, p¼ 0.0002) but not with
the ACT score (r ¼ 0.164, p ¼ 0.0610) (Fig. 1). In contrast, the FSSG
scalewas negatively correlatedwith the LCQ total score (r¼0.351,
p¼ 0.0004) and positively correlated with the CAT score (r ¼ 0.543,
p < 0.0001) (Fig. 2).
Discussion
In this cross-sectional study we assessed whether the effect of
GERD on cough-related quality of life and disease status differs
between patients with asthma and thosewith COPD in a real-world
clinical setting. We found that patients with GERD had signiﬁcantly
more impaired cough-related quality of life that affected all health
domains and poorer asthma control and more symptoms and im-
pacts of COPD than those without GERD. We also found that pa-
tients with COPD had more impaired cough-related quality of life
than those with asthma, regardless of the presence or absence of
GERD.
Previous studies using FSSG reported the prevalence of GERD to
be 25.0%7 and 27.4%17 in Japanese patients with asthma and 26.8%,5
32.5%,7 and 34.0%18 in those with COPD, which were slightly higher
proportions than in the present study. In the comparison between
asthma and COPD, the prevalence of GERD was comparable and
there was no difference in the mean FSSG scale between the two
groups in the present study, whereas a previous study revealed a
higher prevalence in patients with COPD than in those with asthma
(32.5% versus 25.0%), but did not describe the difference in the
mean scale.7 Possible explanations for these discrepancies may bePatients with COPD
(n ¼ 103) GERD (þ) (n ¼ 22) GERD () (n ¼ 80)
1)*** 74 (62e84) 73 (57e86)
19/3 73/7
e46.9)*** 21.6 (13.9e32.6) 20.9 (14.7e30.1)
* 1/20/1 2/67/11
0)*** 45.0 (0e150.0) 51.3 (0e300)
e145.7)*** 56.5 (17.8e109.0) 46.5 (17.0e108.0)
e98.7)*** 56.3 (32.2e68.1) 49.5 (20.8e69.9)
25) NA NA
18.1 (0e32)* 10.0 (0e30)
15.3 (8e34)* 2.4 (0e7)
21.0)*** 16.9 (7.5e21.0)* 19.4 (10.6e21.0)
7.0)*** 5.5 (2.6e7.0)* 6.4 (4.5e7.0)
7.0)*** 5.5 (2.1e7.0)* 6.4 (3.1e7.0)
7.0)*** 5.9 (2.8e7.0)* 6.6 (2.5e7.0)
tory volume in 1 s; FSSG, frequency scale for the symptoms of GERD; FVC, forced vital
A, not applicable.
Fig. 2. Correlations between FSSG scale and LCQ total score (upper panel) and CAT
score (lower panel) in patients with COPD. FSSG scale was negatively correlated with
LCQ total score (r ¼ 0.351, p ¼ 0.0004) and positively correlated with CAT score
(r ¼ 0.543, p < 0.0001). Abbreviations: FSSG, frequency scale for symptoms of GERD;
LCQ, Leicester Cough Questionnaire; CAT, COPD assessment test.
Fig. 1. Correlations between FSSG scale and LCQ total score (upper panel) and ACT
score (lower pane) in patients with asthma. FSSG scale was negatively correlated with
LCQ total score (r ¼ 0.328, p ¼ 0.0002) but not with ACT score (r ¼ 0.164,
p ¼ 0.0610). Abbreviations: FSSG, frequency scale for symptoms of GERD; LCQ,
Leicester Cough Questionnaire; ACT, Asthma Control Test.
T. Shirai et al. / Allergology International 64 (2015) 79e8382the difference in the sample size and the studied population,
including asthma control levels and the backgrounds of the
patients.
Previous studies reported the relationship between GERD and
asthma control. Cheung et al.19 identiﬁed that the patients with
GERD had worse asthma control than those without GERD (mean
ACT score, 19.2 versus 20.2) and that more patients with GERD had
poor asthma control. They also demonstrated that GERD was
associated with a poorer quality of life, as shown by the highly
signiﬁcant difference in all domain scores of the SF-36, a compre-
hensive measure of quality of life. Liang et al.20 found that the in-
dependent association of GERD with not well-controlled asthma
(ACT score <20) after other established contributors to asthma
control were adjusted in multivariate logistic regression analyses.
In the present study, we found that the patients with GERD not only
had signiﬁcantly lower ACT scores than those without GERD but
also signiﬁcantly more impaired cough-related quality of life that
affected all health domains for the ﬁrst time. Further, we demon-
strated a negative correlation between the FSSG scale and LCQ total
score. The lack of correlation between the FSSG scale and ACT score
may reﬂect overall controlled patients with asthma in the present
study. If we had recruited more uncontrolled patients, there would
have been a signiﬁcant correlation between the FSSG scale and ACT
score. We previously assessed the effect of rabeprazole, a proton
pump inhibitor, 10 mg/day on FSSG scale, ACT score, and LCQ total
score in 13 patients with asthma in an uncontrolled, open-label
pilot study.21 We found that each parameter improved signiﬁ-
cantly after 4 months of treatment, suggesting the correlations
between FSSG scale, ACT score, and LCQ total score.
A recent study analyzed the comorbid factors that increase CAT
scores and found that the presence of GERD, depression,
arrhythmia, and anxiety was signiﬁcantly associated with a higher
CAT score in patients with COPD than in those without comorbid-
ities (mean CAT score: GERD, 16.3 versus 10.5).18 In the present
study, we found that patients with COPD and GERD had a higher
CAT score (mean CAT score: 18.1 versus 10.0) and more impaired
cough-related quality of life affecting all health domains than those
without GERD. The correlation between the FSSG scale and LCQ
total score or CAT score suggests that coexisting GERD may affect
not only cough-related quality of life but also the COPD-speciﬁc
health status.
Previous studies have shown that patients with GERD have high
scores of psychological distress. Rey et al.22 found that one-third of
GERD patients with typical symptoms as the main complaint
attending a gastroenterologist ofﬁce were psychological distressed
compared to the age- and sex-matched healthy controls. Cheung
et al.19 reported that the asthmatic patients with GERD had more
anxiety and depression as reﬂected by the Hospital Anxiety and
Depression Scale than those without GERD. Also, depression and
anxiety are well-known comorbidities in COPD.18 A recent study
compared the psychological aspects between asthma and COPD,
and found that patients with COPD, but not those with asthma,
exhibited signiﬁcantly higher levels of depressive and anxiety
symptoms than healthy controls.23 Also, in the present study, we
conﬁrmed that the patients with GERD had more impaired cough-
related quality of life affecting the psychological domain than those
without GERD in both asthma and COPD. Compared to patients
with asthma and GERD, patients with COPD and GERD had a more
impaired psychological domain of the LCQ, suggesting the differ-
ence in the psychological aspects of the diseases.
Cough is identiﬁed by asthmatic patients as a symptom that
signiﬁcantly interferes with activities of daily life.24 Cough is also
recognized by physicians as a very important symptom in deter-
mining asthma control, although less so than shortness of breath
and wheezing.25 In COPD, chronic coughing and sputum
T. Shirai et al. / Allergology International 64 (2015) 79e83 83production are present in a subset of patients and are related to
disease progression.26 Patients with asthma or COPD in the present
study were clinically well controlled or stable; however, the LCQ
scores in patients with COPD were signiﬁcantly lower than in pa-
tients with asthma. This difference was also observed in the com-
parison between patients with asthma and without GERD and
those with COPD and without GERD. A previous study compared
the LCQ between clinically stable patients with asthma or COPD
who did not report coughing as a prominent or troublesome
symptom and found no difference in the total LCQ score (13.3
versus 13.2).27 The small sample size in their study may explain the
discrepancy but the ﬁndings in the present study may suggest a
difference in the degree of coughing between asthma and COPD,
even in a stable condition.
The relationship between GERD and age or BMI is controversial
in Japan. Some investigators28,29 reported old age (over 80 years)
and obesity (25 kg/m2) as risk factors, whereas others found
different results. Watanabe et al.30 found that of the total 4139
subjects the prevalence of GERD diagnosed by the FSSGwas highest
in the 20e29 years age group and lowest in the 70e79 years group.
Furukawa et al.28 failed to show any signiﬁcant difference in the
proportion of esophagitis between patients with BMI (25 kg/m2)
and those with BMI (<25 kg/m2). In the present study, the asthma
patients with GERD were younger than those without GERD. And
there was no difference in the BMI between the two groups.
Different populations may produce different results.
The major limitation of this study is that group characteristics,
such as age and gender, did notmatch between the two groups, and
it would be difﬁcult to compare the effects of GERD between the
groups directly; however, the purpose of this study was to evaluate
the effect of GERD on cough-related quality of life and disease
status in asthma and COPD in a real-world setting. We believe we
could clarify the clinical features of patients with GERD both in
asthma and COPD. Concerning the difference in GERD symptoms
and the impact of GERD symptoms on exacerbation between age-
matched patients with asthma and those with COPD, Shimizu
et al.7 found that patients with asthma had more regurgitation-
related symptoms than those with COPD, whereas patients with
COPD had more dysmotility-related symptoms than those with
asthma. They also found that the presence of GERD inﬂuenced the
exacerbation of COPD, but not asthma. Real-world effect of GERD in
the present study should be interpreted in conjunction with the
ﬁndings reported by Shimizu et al.
In conclusion, patients with GERD and asthma or COPD had
impaired cough-related quality of life and poor asthma control or
more symptoms and impacts of COPD.
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